Table 3.

Double- and triple-combination therapy trials in chronic and advanced phases of myelofibrosis

Double- and triple-combination therapy trials in chronic and advanced phases of myelofibrosis

* Stage 2 of the phase II trial will only evaluate PRM-151 as monotherapy.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal